Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Combined Use of Neutrophil to Lymphocyte Ratio and C-Reactive Protein Level to Predict Clinical Outcomes in Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention

  • Shin, Ho-Cheol (Department of Internal Medicine, Busan Paik Hospital, Inje University College of Medicine) ;
  • Jang, Jae-Sik (Department of Internal Medicine, Busan Paik Hospital, Inje University College of Medicine) ;
  • Jin, Han-Young (Department of Internal Medicine, Busan Paik Hospital, Inje University College of Medicine) ;
  • Seo, Jeong-Sook (Department of Internal Medicine, Busan Paik Hospital, Inje University College of Medicine) ;
  • Yang, Tae-Hyun (Department of Internal Medicine, Busan Paik Hospital, Inje University College of Medicine) ;
  • Kim, Dae-Kyeong (Department of Internal Medicine, Busan Paik Hospital, Inje University College of Medicine) ;
  • Kim, Dong-Soo (Department of Internal Medicine, Busan Paik Hospital, Inje University College of Medicine)
  • Received : 2016.09.13
  • Accepted : 2016.12.30
  • Published : 2017.05.31
⟨ Previous Next ⟩

Abstract

Background and Objectives: Both neutrophil to lymphocyte ratio (NLR) and C-reactive protein (CRP) are biomarkers associated with poor prognosis of patients with acute myocardial infarction (AMI). However, the combined usefulness of NLR and CRP in predicting adverse outcomes has not been investigated. Subjects and Methods: We analyzed 381 consecutive AMI patients who underwent percutaneous coronary intervention (PCI) from January 2012 to January 2014. The endpoints were all-cause mortality, recurrent myocardial infarction (MI), stent thrombosis, repeat revascularization, stroke, and major adverse cardiac and cerebrovascular events (MACCE) at 2-year follow-up. Included patients were divided into 4 groups according to the optimal cut-off values for NLR and CRP on receiver operating characteristic analysis predicting mortality. Results: Patients with both high NLR (>6.30) and high CRP (>0.76) had significantly greater risk of all-cause death and MACCE at 24 months, with no significant increase in the risk of recurrent MI, stent thrombosis, or stroke compared with patients with either low NLR or low CRP, as well as those with low NLR and low CRP. Kaplan-Meier analysis revealed significantly lower survival in patients with high NLR-CRP. On Cox multivariate analysis, high NLR-CRP (hazard ratio 23.172, 95% confidence interval 6.575 to 81.671, p<0.001) was an independent predictor of all-cause death. Conclusion: Elevated levels of both NLR and CRP are associated with increased risk of long-term mortality in AMI patients who have undergone PCI.

Keywords

References

  1. Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med 1999;340:115-26. https://doi.org/10.1056/NEJM199901143400207
  2. Libby P, Ridker PM, Hansson GK; Leducq Transatlantic Network on Atherothrombosis. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009;54:2129-38. https://doi.org/10.1016/j.jacc.2009.09.009
  3. Ogita M, Miyauchi K, Tsuboi S, et al. Impact of combined C-reactive protein and high-density lipoprotein cholesterol levels on long-term outcomes in patients with coronary artery disease after a first percutaneous coronary intervention. Am J Cardiol 2015;116:999-1002. https://doi.org/10.1016/j.amjcard.2015.06.036
  4. Han YC, Yang TH, Kim DI, et al. Neutrophil to lymphocyte ratio predicts long-term clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Korean Circ J 2013;43:93-9. https://doi.org/10.4070/kcj.2013.43.2.93
  5. Gibson PH, Croal BL, Cuthbertson BH, et al. Preoperative neutrophillymphocyte ratio and outcome from coronary artery bypass grafting. Am Heart J 2007;154:995-1002. https://doi.org/10.1016/j.ahj.2007.06.043
  6. Gibson PH, Cuthbertson BH, Croal BL, et al. Usefulness of neutrophil/lymphocyte ratio as predictor of new-onset atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 2010;105:186-91. https://doi.org/10.1016/j.amjcard.2009.09.007
  7. Nakamura T, Matsumine A, Matsubara T, Asanuma K, Uchida A, Sudo A. The combined use of the neutrophil-lymphocyte ratio and C-reactive protein level as prognostic predictors in adult patients with soft tissue sarcoma. J Surg Oncol 2013;108:481-5. https://doi.org/10.1002/jso.23424
  8. O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation 2013;127:e362-425.
  9. Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol 2014;64:e139-228. https://doi.org/10.1016/j.jacc.2014.09.017
  10. Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007;115:2344-51. https://doi.org/10.1161/CIRCULATIONAHA.106.685313
  11. Azab B, Zaher M, Weiserbs KF, et al. Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction. Am J Cardiol 2010;106:470-6. https://doi.org/10.1016/j.amjcard.2010.03.062
  12. Tamhane UU, Aneja S, Montgomery D, Rogers EK, Eagle KA, Gurm HS. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol 2008;102:653-7. https://doi.org/10.1016/j.amjcard.2008.05.006
  13. Fowler AJ, Agha RA. Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography--the growing versatility of NLR. Atherosclerosis 2013;228:44-5. https://doi.org/10.1016/j.atherosclerosis.2013.02.008
  14. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361:13-20. https://doi.org/10.1016/S0140-6736(03)12113-7
  15. Forman MB, Puett DW, Virmani R. Endothelial and myocardial injury during ischemia and reperfusion: pathogenesis and therapeutic implications. J Am Coll Cardiol 1989;13:450-9. https://doi.org/10.1016/0735-1097(89)90526-3
  16. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined--a consensus document of the joint european society of cardiology/american college of cardiology committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-69. https://doi.org/10.1016/S0735-1097(00)00804-4
  17. De Servi S, Mariani M, Mariani G, Mazzone A. C-reactive protein increase in unstable coronary disease cause or effect? J Am Coll Cardiol 2005;46:1496-502. https://doi.org/10.1016/j.jacc.2005.05.083
  18. Hansson GK, Libby P, Tabas I. Inflammation and plaque vulnerability. J Intern Med 2015;278:483-93. https://doi.org/10.1111/joim.12406
  19. Agrawal A, Gang TB, Rusinol AE. Recognition functions of pentameric C-reactive protein in cardiovascular disease. Mediators Inflamm 2014;2014:319215.
  20. Deftereos S, Giannopoulos G, Angelidis C, et al. Anti-inflammatory treatment with colchicine in acute myocardial infarction: a pilot study. Circulation 2015;132:1395-403. https://doi.org/10.1161/CIRCULATIONAHA.115.017611
  21. Ugur M, Gul M, Bozbay M, et al. The relationship between platelet to lymphocyte ratio and the clinical outcomes in ST elevation myocardial infarction underwent primary coronary intervention. Blood Coagul Fibrinolysis 2014;25:806-11. https://doi.org/10.1097/MBC.0000000000000150
  22. Temiz A, Gazi E, Gungor O, et al. Platelet/lymphocyte ratio and risk of in-hospital mortality in patients with ST-elevated myocardial infarction. Med Sci Monit 2014;20:660-5. https://doi.org/10.12659/MSM.890152
  23. Sari I, Sunbul M, Mammadov C, et al. Relation of neutrophil-tolymphocyte and platelet-to-lymphocyte ratio with coronary artery disease severity in patients undergoing coronary angiography. Kardiol Pol 2015;73:1310-6. https://doi.org/10.5603/KP.a2015.0098
  24. Cho KI, Ann SH, Singh GB, Her AY, Shin ES. Combined usefulness of the platelet-to-lymphocyte ratio and the neutrophil-to-lymphocyte ratio in predicting the long-term adverse events in patients who have undergone percutaneous coronary intervention with a drugeluting stent. PLoS One 2015;10:e0133934. https://doi.org/10.1371/journal.pone.0133934
  25. Helmers C. Short and long-term prognostic indices in acute myocardial infarction. A study of 606 patients initially treated in a coronary care unit. Acta Med Scand Suppl 1973;555:7-26.
  26. Kelly TL, Gilpin E, Ahnve S, Henning H, Ross J Jr. Smoking status at the time of acute myocardial infarction and subsequent prognosis. Am Heart J 1985;110:535-41. https://doi.org/10.1016/0002-8703(85)90071-7
  27. Sparrow D, Dawber TR. The influence of cigarette smoking on prognosis after a first myocardial infarction. A report from the Framingham study. J Chronic Dis 1978;31:425-32. https://doi.org/10.1016/0021-9681(78)90006-1
  28. Weinblatt E, Shapiro S, Frank CW, Sager RV. Prognosis of men after first myocardial infarction: mortality and first recurrence in relation to selected parameters. Am J Public Health Nations Health 1968;58:1329-47. https://doi.org/10.2105/AJPH.58.8.1329
  29. Aune E, Roislien J, Mathisen M, Thelle DS, Otterstad JE. The "smoker's paradox" in patients with acute coronary syndrome: a systematic review. BMC Med 2011;9:97. https://doi.org/10.1186/1741-7015-9-97
  30. Misumida N, Kobayashi A, Kanei Y. Racial differences in the neutrophil-to-lymphocyte ratio in patients with non-ST-segment elevation myocardial infarction. Coron Artery Dis 2015;26:381-5. https://doi.org/10.1097/MCA.0000000000000237

Cited by

  1. Association between neutrophil to lymphocyte ratio on admission and grace mortality risk score among acute myocardial infarction patient at BRSUD Tabanan in 2017 vol.434, pp.None, 2017, https://doi.org/10.1088/1757-899x/434/1/012147
  2. Correlation between neutrophil count and prognosis in STEMI patients with chronic renal dysfunction: a retrospective cohort study vol.14, pp.1, 2017, https://doi.org/10.1515/biol-2019-0075
  3. Correlation between neutrophil count and prognosis in STEMI patients with chronic renal dysfunction: a retrospective cohort study vol.14, pp.1, 2017, https://doi.org/10.1515/biol-2019-0075
  4. The relationship of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in peripheral blood with ST-segment resolution and the clinical outcomes of STEMI patients receiving thrombolytic th vol.57, pp.1, 2017, https://doi.org/10.2478/rjim-2018-0031
  5. Correlations and Prognostic Roles of the Nutritional Status and Neutrophil-to-lymphocyte Ratio in Elderly Patients with Acute Myocardial Infarction Undergoing Primary Coronary Intervention vol.61, pp.6, 2017, https://doi.org/10.1536/ihj.20-138
  6. Prognostic value of the combination of GRACE risk score and mean platelet volume to lymphocyte count ratio in patients with ST-segment elevation myocardial infarction after percutaneous coronary inter vol.19, pp.6, 2017, https://doi.org/10.3892/etm.2020.8626
  7. The combination of neutrophil-to-lymphocyte ratio and platelet correlation parameters in predicting the no-reflow phenomenon after primary percutaneous coronary intervention in patients with ST-segmen vol.54, pp.6, 2017, https://doi.org/10.1080/14017431.2020.1783457